North Carolina [US], July 31 (ANI): A new study shows that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.
Maryland [US], July 30 (ANI): During a recent study, researchers found that a combination of the immunotherapy drug nivolumab and the kinase-inhibitor drug cabozantinib can make curative surgery possible in some liver cancer patients who would normally not be considered surgical candidates.